AbbVie sets up shop in Singapore

Share this article:

AbbVie is establishing roots in Asia. The drugmaker announced Thursday that it was investing $320 million to build the manufacturing facility in Singapore—its first manufacturing site in all of Asia. The site will be focused on emerging oncology and immunology products.

The company said in a statement it expects the site will be fully operational by 2019 and will employ around 250.

AbbVie split from Abbott Laboratories in January 2013.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.